Investment details
Entry
Staff
8Location
USAI am grateful to be working with a top-tier group of investors and drug developers who are inspired by patients, fueled by data to rapidly develop transformative cancer medicines
Mohit Trikha, Ph.D.
President & COO
Partnership Gimv
The ambition of Kivu Bioscience holds great potential to significantly enhance patient outcomes in the future. We are excited to work alongside co-investors and the management team to join forces and make Kivu a leading ADC company while bringing new therapeutic solutions to the market.
Deal Team
Related news Related news Related news